Arena Pharmaceuticals Issued Patent for 5-HT2A Receptor Modulators by European Patent Office
APD125, Arena's Drug Candidate for the Treatment of Insomnia, Covered Under Patent
02-Jan-2006
Organizations
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.